PATENT CLAIM ANALYSIS

Application Number: 16313360
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "001110"]

Abstract:
The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERRγ) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the arylethene derivative is an arylethene derivative represented by the following Chemical Formulae 2 to 5: wherein   denotes a single bond or a double bond; and R 1 , Ar and R 2  are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 26.0
- Percentile: 98.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15102968', '12704343', '11829531', '13098247', '14473147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7016042618943595
- 35 USC 102 Novelty (BERT): 0.5267055689441881
- Combined Prediction Score: 0.6841143925993424
- Mean Citation Score: 290.742902
- Max Citation Score: 305.64383
- Similarity Product: 204.243946339491

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test